副干酪乳杆菌
N/A
Report date: 2024/01/17 14:42:01
Base Information
Drug Name副干酪乳杆菌
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesNestléMerck Medication Familiale
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A